GNLN — Greenlane Holdings, Inc.
NASDAQ
Q2 2023 Earnings Call Summary
August 14, 2023
Summary of Greenlane Holdings (GNLN) Q2 2023 Earnings Call
1. Key Financial Results and Metrics
- Total Net Sales: $19.6 million, down 18.1% from Q1 2023 ($24 million) and down 51% year-over-year from Q2 2022 ($39.9 million).
- Gross Profit: $4.6 million, a decrease of $900,000 from Q1 2023; gross margin slightly improved to 23.3% from 23% in Q1 2023.
- Operating Expenses: Reduced to $14.1 million from $15 million in Q1 2023, and down 35.2% year-over-year from $21.8 million in Q2 2022.
- Net Loss: $10.5 million or $6.56 per share, slightly higher than the loss of $10.2 million in Q1 2023; improved from a loss of $14.5 million in Q2 2022.
- Adjusted EBITDA Loss: $5.9 million, improved from a loss of $6.8 million in Q1 2023.
- Cash Position: Ended Q2 with $4.7 million in cash and $14.2 million in working capital, down from $5.9 million and $25.7 million respectively at the end of Q1 2023.
2. Strategic Updates and Business Highlights
- Focus on profitability and innovation, with the launch of five new products in the e-cigarette and cannabis accessory segments.
- Transitioning to an asset-light model, particularly in the industrial segment, which is expected to improve margins despite moderating revenues.
- Significant cost reductions achieved through facility consolidations and workforce reductions, with an annual savings projection of over $4 million from facility closures.
- The company is expanding into the disposable nicotine product market, anticipating significant revenue growth from this segment.
3. Forward Guidance and Outlook
- Management expects continued reductions in operating expenses in Q3 and Q4, driven by aggressive cost management strategies.
- Anticipation of improved gross margins due to the asset-light model and new product offerings, particularly in the nicotine space.
- Positive outlook on revenue growth from partnerships with major manufacturers and brands in the nicotine industry.
4. Bad News, Challenges, or Points of Concern
- Revenue decline attributed to seasonality, a shift from gross to net revenue recognition, and restructuring efforts.
- The company reported a net loss that has not improved quarter-over-quarter, raising concerns about the pace of recovery.
- The ongoing need for significant cost reductions and the impact of severance charges related to former executives, which may cloud future financial improvements.
- Competitive pressures in the cannabis and nicotine markets, with a need to adapt to changing consumer preferences and pricing dynamics.
5. Notable Q&A Insights
- Management emphasized that the path to profitability will involve both expense reductions and revenue growth, particularly from new product launches and the nicotine segment.
- There is a strong demand for nicotine products, and management expects to see a significant lift in sales in the latter half of Q3.
- The company is deepening its relationships with multi-state operators (MSOs) and adapting to the retail-centric analytics that are becoming more critical in the cannabis market.
Overall, while GNLN is facing challenges with declining revenues and net losses, the company is actively pursuing strategic initiatives to improve profitability and position itself for future growth.
